Randomized Controlled Trial Evaluating the Safety, Efficacy, and Patient Comfort of a Single‐Use Electronic Colonoscope
Journal of Gastroenterology and Hepatology · 2026-06 · 41 (6) · 1751-1759
DOI: 10.1111/jgh.70387 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 20.04.2026. Verfasst von Yuan Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy Center, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Colonoscopes, Colonoscopy, Patient Comfort. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Capital Funds for Health Improvement and Research, National High Level Hospital Clinical Research (Research Achievement Transformation Project of Peking University First Hospital).
Abstract (Originalsprache)
Background and Aim Although reusable colonoscopes remain the clinical gold standard, persistent microbial biofilms compromise reprocessing efficacy and increase cross‐contamination risk. This study evaluated a novel single‐use colonoscope compared to a conventional device across key clinical and patient‐centered outcomes.
Methods
In a single‐blind randomized trial, 100 patients (aged 18–80 years) undergoing conscious sedation colonoscopy were assigned (1:1) to a single‐use colonoscope (Endofresh XZING‐C200B) or a conventional colonoscope (Olympus CF‐H260). Primary endpoints included patient comfort (assessed via real‐time grip strength dynamometry), therapeutic endoscopic mucosal resection (EMR) efficacy, adenoma detection rate (ADR), adenomas per colonoscopy (APC), and cecal intubation time.
Results
Groups were demographically balanced. No significant differences were observed in patient comfort ( p > 0.05), EMR outcomes (100% en bloc resection; median procedure times: 11.32 ± 4.55 vs. 11.57 ± 7.95 min, p = 0.899), diagnostic performance (ADRs: 56% vs. 60%, p = 0.685; APCs median: 1.0 vs. 1.0, p = 0.349), or cecal intubation time (7.47 ± 5.81 vs. 6.13 ± 4.06 min, p = 0.185). One sigmoid colon cancer was detected per group. The single‐use device showed inferior image quality and far‐field brightness (both p < 0.001).
Conclusions
In this exploratory randomized trial, the novel single‐use colonoscope demonstrated clinical efficacy and safety profiles comparable to the conventional system. These preliminary findings support its potential for integration into routine screening, pending confirmation in larger noninferiority studies. Chinese Clinical Trial Registry: ChiCTR2400082142.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endoscopy Center, Peking University First Hospital, Beijing, China.
ORCID-Profile: Long Rong
Förderung
- Capital Funds for Health Improvement and Research
- National High Level Hospital Clinical Research (Research Achievement Transformation Project of Peking University First Hospital)
Zitieren
APA
Tian, Y., Rao, X., Yu, H., Zheng, L., Wang, A., Liu, S., He, Y., & Rong, L. (2026). Randomized Controlled Trial Evaluating the Safety, Efficacy, and Patient Comfort of a Single‐Use Electronic Colonoscope. Journal of Gastroenterology and Hepatology, 41(6), 1751-1759. https://doi.org/10.1111/jgh.70387
Vancouver
Tian Y, Rao X, Yu H, Zheng L, Wang A, Liu S, et al. Randomized Controlled Trial Evaluating the Safety, Efficacy, and Patient Comfort of a Single‐Use Electronic Colonoscope. Journal of Gastroenterology and Hepatology. 2026;41(6):1751-1759. doi:10.1111/jgh.70387
BibTeX
@article{Tian2026,
author = {Tian, Yuan and Rao, Xiaolong and Yu, Hang and Zheng, Lingfeng and Wang, Ao and Liu, Shuangjiao and He, Yan and Rong, Long},
title = {Randomized Controlled Trial Evaluating the Safety, Efficacy, and Patient Comfort of a Single‐Use Electronic Colonoscope},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {6},
pages = {1751--1759},
doi = {10.1111/jgh.70387}
}
EUVIMED